Discover how you can treat specific autoimmune and autoimflammatory conditions with HADLIMA™ (adalimumab-bwwd), an FDA-approved biosimilar of HUMIRA (adalimumab).

Learn more about HADLIMA™ (adalimumab-bwwd), which is an FDA-approved biosimilar to HUMIRA (adalimumab), and discover what HADLIMA is used to treat and how it may help you.

Review dosing and administration options for HADLIMA™ (adalimumab-bwwd) and watch a video with step-by-step injection instructions.

Find co-pay assistance for HADLIMA™ (adalimumab-bwwd). Enroll now to receive personalized support and ways to save on your prescription for HADLIMA.

Even with commercial insurance, Jennifer was struggling to afford her prescribed doses of HUMIRA. She had a 25% co-insurance responsibility, which required her to pay $1,730 every month. Her doctor recommended switching to HADLIMA in an effort to help her save without compromising treatment.

Serious infections have happened in people taking adalimumab products. These serious infections include tuberculosis (TB) and infections caused by viruses, fungi, or bacteria that have spread throughout the body.